Gilead Sciences (GILD) Net Income Attributable to Noncontrolling Interests (2009 - 2023)
Gilead Sciences (GILD) reported Net Income Attributable to Noncontrolling Interests of -$12 million for Q4 2023, compared with -$7 million a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Net Income Attributable to Noncontrolling Interests (2009 - 2023) Analysis & Trends
For FY2023, Gilead Sciences posted Net Income Attributable to Noncontrolling Interests of -$52 million.
- By year, Net Income Attributable to Noncontrolling Interests came in at -$26 million in FY2022, -$24 million in FY2021, -$34 million in FY2020 and -$22 million in FY2019.
- Five-year quarterly Net Income Attributable to Noncontrolling Interests spans a low of -$26 million in Q1 2023 and a high of -$3 million in Q3 2022.
- Per Business Quant data, the three quarters before Q4 2023 came in at -$8 million (Q3 2023), -$6 million (Q2 2023) and -$26 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -12.00 Mn |
| Sep 30, 2023 | -8.00 Mn |
| Jun 30, 2023 | -6.00 Mn |
| Mar 31, 2023 | -26.00 Mn |
| Dec 31, 2022 | -7.00 Mn |
| Sep 30, 2022 | -3.00 Mn |
| Jun 30, 2022 | -9.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Dec 31, 2021 | -6.00 Mn |
| Sep 30, 2021 | -6.00 Mn |
| Jun 30, 2021 | -5.00 Mn |
| Mar 31, 2021 | -7.00 Mn |
| Dec 31, 2020 | -7.00 Mn |
| Sep 30, 2020 | -7.00 Mn |
| Jun 30, 2020 | -7.00 Mn |
| Mar 31, 2020 | -13.00 Mn |
| Dec 31, 2019 | -7.00 Mn |
| Sep 30, 2019 | -3.00 Mn |
| Jun 30, 2019 | -5.00 Mn |
| Mar 31, 2019 | -7.00 Mn |
API Access
Gilead Sciences Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();